Trials / Sponsors / Sesen Bio, Inc.
Sesen Bio, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG Bladder Cancer | Phase 3 | 2015-08-01 |
| Terminated | Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin Neoplasms, Glandular and Epithelial | Phase 1 | 2007-05-01 |
| Completed | Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ Urinary Bladder Cancer, Bladder Cancer, Bladder Neoplasms | Phase 2 | 2007-03-01 |
| Terminated | Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell, Neoplasms, Squamous Cell | Phase 2 | 2006-01-01 |
| Terminated | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and N Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Squamous Cell, Neoplasms, Squamous Cell | Phase 2 / Phase 3 | 2005-12-01 |